Christopher G. Goetz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher G. Goetz has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Glenn T. Stebbins
Rush University Medical Center
4 shared publications - Sheng Luo
Duke University
4 shared publications Glenn T. Stebbins
Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA
3 shared publications- Brian Christopher Smith
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, USA
2 shared publications - Brian D. Berman
Department of Neurology, Virginia Commonwealth University, United States
2 shared publications - Cynthia Comella
Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA
2 shared publications
Latest Publications
- Open Access
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5031
Participant and Provider Perspectives on a Novel Virtual Home Safety Program for Fall Prevention in Parkinson’s Disease
Background/Objectives: Telehealth enhances access to specialty care, but stakeholder perspectives are often overlooked. The objective was to evaluate participant and provider satisfaction with a novel telehealth-enabled home safety program. Methods: This is a sub-investigation of a non-randomized pilot study of a novel telehealth-enabled home safety program that enrolled 23 persons with Parkinson’s Disease (PwPs) at risk for falls and their respective care partners (CPs). Dyads participated in four to six televisits over three months, where they performed “virtual home tours” using a mobile platform (tablet mounted on a rolling stand) with a physical therapist to identify and mitigate environmental fall hazards. Satisfaction was assessed using PI-developed surveys and open feedback. Mobile platform usability was assessed with the System Usability Scale (SUS). Results: A total of 95.65% of dyads were very to extremely satisfied with the entire program overall, and the therapist indicated the same for 73.91% of the dyads. Additionally, 95.65% of dyads reported gaining new awareness of home fall hazards. Difficulties maneuvering the mobile platform, using a tablet, and connectivity issues were common challenges noted. The mean score on SUS for the mobile platform was 65, indicating poor perceived usability, and most dyads indicated they would have preferred using a smartphone for the program. Other priorities, including competing health and personal obligations, along with resistance to change, were the primary barriers to implementing program recommendations. Conclusions: Our novel telehealth-enabled home safety program was well-received by patients and the study therapist. Using a smartphone and troubleshooting connectivity issues might help further improve the usability and accessibility of this program.
- 16 July 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (14) , 5031
Open AccessParticipant and Provider Perspectives on a Novel Virtual Home Safety Program for Fall Prevention in Parkinson’s Disease
Background/Objectives: Telehealth enhances access to specialty care, but stakeholder perspectives are often overlooked. The objective was to evaluate participant and provider satisfaction with a novel telehealth-enabled home safety program. Methods: This is a sub-investigation of a non-randomized pilot study of a novel telehealth-enabled home safety program that enrolled 23 persons with Parkinson’s Disease (PwPs) at risk for falls and their respective care partners (CPs). Dyads participated in four to six televisits over three months, where they performed “virtual home tours” using a mobile platform (tablet mounted on a rolling stand) with a physical therapist to identify and mitigate environmental fall hazards. Satisfaction was assessed using PI-developed surveys and open feedback. Mobile platform usability was assessed with the System Usability Scale (SUS). Results: A total of 95.65% of dyads were very to extremely satisfied with the entire program overall, and the therapist indicated the same for 73.91% of the dyads. Additionally, 95.65% of dyads reported gaining new awareness of home fall hazards. Difficulties maneuvering the mobile platform, using a tablet, and connectivity issues were common challenges noted. The mean score on SUS for the mobile platform was 65, indicating poor perceived usability, and most dyads indicated they would have preferred using a smartphone for the program. Other priorities, including competing health and personal obligations, along with resistance to change, were the primary barriers to implementing program recommendations. Conclusions: Our novel telehealth-enabled home safety program was well-received by patients and the study therapist. Using a smartphone and troubleshooting connectivity issues might help further improve the usability and accessibility of this program.
- Open Access
- 10 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (3) , 108289
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomains
- 10 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (3) , 108289
Open AccessMultivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomains
- Open Access
- 7 March 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (4) , 107146
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression
- 7 March 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (4) , 107146
Open AccessCancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression
- Open Access
- 17 March 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (3) , 506
Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study
The genetic basis of Neurogenic Orthostatic Hypotension (NOH) in Parkinson’s disease (PD) has been inadequately explored. In a cross-sectional study, we examined the association between NOH and PD-related single-nucleotide polymorphisms (SNPs) and mapped their effects on gene expression and metabolic and signaling pathways. Patients with PD, free from pathological conditions associated with OH, and not taking OH-associated medications were included. NOH was defined as per international guidelines. Logistic regression was used to relate SNPs to NOH. Linkage-disequilibrium analysis, expression quantitative trait loci, and enrichment analysis were used to assess the effects on gene expression and metabolic/signaling pathways. We included 304 PD patients in the study, 35 of whom had NOH (11.5%). NOH was more frequent in patients with SNPs in SNCA, TMEM175, FAM47E-STBD1, CCDC62, SCN3A, MIR4696, SH3GL2, and LZTS3/DDRGK1 and less frequent in those with SNPs in ITGA8, IP6K2, SIPA1L2, NDUFAF2. These SNPs affected gene expression associated with the significant hierarchical central structures of the autonomic nervous system. They influenced several metabolic/signaling pathways, most notably IP3/Ca++ signaling, the PKA-CREB pathway, and the metabolism of fatty acids. These findings provide new insights into the pathophysiology of NOH in PD and may provide targets for future therapies.
- 17 March 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (3) , 506
Open AccessGenetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study
The genetic basis of Neurogenic Orthostatic Hypotension (NOH) in Parkinson’s disease (PD) has been inadequately explored. In a cross-sectional study, we examined the association between NOH and PD-related single-nucleotide polymorphisms (SNPs) and mapped their effects on gene expression and metabolic and signaling pathways. Patients with PD, free from pathological conditions associated with OH, and not taking OH-associated medications were included. NOH was defined as per international guidelines. Logistic regression was used to relate SNPs to NOH. Linkage-disequilibrium analysis, expression quantitative trait loci, and enrichment analysis were used to assess the effects on gene expression and metabolic/signaling pathways. We included 304 PD patients in the study, 35 of whom had NOH (11.5%). NOH was more frequent in patients with SNPs in SNCA, TMEM175, FAM47E-STBD1, CCDC62, SCN3A, MIR4696, SH3GL2, and LZTS3/DDRGK1 and less frequent in those with SNPs in ITGA8, IP6K2, SIPA1L2, NDUFAF2. These SNPs affected gene expression associated with the significant hierarchical central structures of the autonomic nervous system. They influenced several metabolic/signaling pathways, most notably IP3/Ca++ signaling, the PKA-CREB pathway, and the metabolism of fatty acids. These findings provide new insights into the pathophysiology of NOH in PD and may provide targets for future therapies.
- 8 December 2022
- Published by Wiley in Movement Disorders
- Vol. 38 (2) , 342-347
It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum
Background: Original clinimetric analyses by the Movement Disorder Society–sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) developers did not confirm the validity of summing the scores of its parts. Recent studies used the summed score of Part III and other parts as efficacy outcomes.Objective: The aim of this study was to establish whether summing scores of MDS‐UPDRS parts can be recommended.Methods: Using 7466 full MDS‐UPDRS scores, we applied two‐step factor analysis as in the original article to reassess the validity analysis with the threshold criterion set at comparative fit index ≥0.9.Results: All comparative fit indexes of any combination including Part III were lower than 0.90.Conclusions: Summing Part III MDS‐UPDRS scores with other parts is not clinimetrically sound. The MDS‐UPDRS is a validated four‐part scale with corresponding individual part scores and needs to be used within the limits originally presented. © 2022 International Parkinson and Movement Disorder Society.
- 8 December 2022
- Published by Wiley in Movement Disorders
- Vol. 38 (2) , 342-347
It Is as It Was: MDS‐UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum
Background: Original clinimetric analyses by the Movement Disorder Society–sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) developers did not confirm the validity of summing the scores of its parts. Recent studies used the summed score of Part III and other parts as efficacy outcomes.Objective: The aim of this study was to establish whether summing scores of MDS‐UPDRS parts can be recommended.Methods: Using 7466 full MDS‐UPDRS scores, we applied two‐step factor analysis as in the original article to reassess the validity analysis with the threshold criterion set at comparative fit index ≥0.9.Results: All comparative fit indexes of any combination including Part III were lower than 0.90.Conclusions: Summing Part III MDS‐UPDRS scores with other parts is not clinimetrically sound. The MDS‐UPDRS is a validated four‐part scale with corresponding individual part scores and needs to be used within the limits originally presented. © 2022 International Parkinson and Movement Disorder Society.
- 16 July 2022
- Published by Wiley in Movement Disorders
- Vol. 37 (9) , 1904-1914
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling
Background: Longitudinal item response theory (IRT) models previously suggested that the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) motor examination has two salient domains, tremor and nontremor, that progress in time and in response to treatment differently.Objective: Apply longitudinal IRT modeling, separating tremor and nontremor domains, to reanalyze outcomes in the previously published clinical trial (Study of Urate Elevation in Parkinson's Disease, Phase 3) that showed no overall treatment effects.Methods: We applied unidimensional and multidimensional longitudinal IRT models to MDS‐UPDRS motor examination items in 298 participants with Parkinson's disease from the Study of Urate Elevation in Parkinson's Disease, Phase 3 (placebo vs. inosine) study. We separated 10 tremor items from 23 nontremor items and used Bayesian inference to estimate progression rates and sensitivity to treatment in overall motor severity and tremor and nontremor domains.Results: The progression rate was faster in the tremor domain than the nontremor domain before levodopa treatment. Inosine treatment had no effect on either domain relative to placebo. Levodopa treatment was associated with greater slowing of progression in the tremor domain than the nontremor domain regardless of inosine exposure. Linear patterns of progression were observed. Despite different domain‐specific progression patterns, tremor and nontremor severities at baseline and over time were significantly correlated.Conclusions: Longitudinal IRT analysis is a novel statistical method addressing limitations of traditional linear regression approaches. It is particularly useful because it can simultaneously monitor changes in different, but related, domains over time and in response to treatment interventions. We suggest that in neurological diseases with distinct impairment domains, clinical or anatomical, this application may identify patterns of change unappreciated by standard statistical methods. © 2022 International Parkinson and Movement Disorder Society.
- 16 July 2022
- Published by Wiley in Movement Disorders
- Vol. 37 (9) , 1904-1914
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling
Background: Longitudinal item response theory (IRT) models previously suggested that the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS‐UPDRS) motor examination has two salient domains, tremor and nontremor, that progress in time and in response to treatment differently.Objective: Apply longitudinal IRT modeling, separating tremor and nontremor domains, to reanalyze outcomes in the previously published clinical trial (Study of Urate Elevation in Parkinson's Disease, Phase 3) that showed no overall treatment effects.Methods: We applied unidimensional and multidimensional longitudinal IRT models to MDS‐UPDRS motor examination items in 298 participants with Parkinson's disease from the Study of Urate Elevation in Parkinson's Disease, Phase 3 (placebo vs. inosine) study. We separated 10 tremor items from 23 nontremor items and used Bayesian inference to estimate progression rates and sensitivity to treatment in overall motor severity and tremor and nontremor domains.Results: The progression rate was faster in the tremor domain than the nontremor domain before levodopa treatment. Inosine treatment had no effect on either domain relative to placebo. Levodopa treatment was associated with greater slowing of progression in the tremor domain than the nontremor domain regardless of inosine exposure. Linear patterns of progression were observed. Despite different domain‐specific progression patterns, tremor and nontremor severities at baseline and over time were significantly correlated.Conclusions: Longitudinal IRT analysis is a novel statistical method addressing limitations of traditional linear regression approaches. It is particularly useful because it can simultaneously monitor changes in different, but related, domains over time and in response to treatment interventions. We suggest that in neurological diseases with distinct impairment domains, clinical or anatomical, this application may identify patterns of change unappreciated by standard statistical methods. © 2022 International Parkinson and Movement Disorder Society.
- Open Access
- 23 June 2021
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 11 (1)
Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia?
A defining characteristic of dystonia is its position-dependence. In cervical dystonia (CD), sensory tricks ameliorate head tremor (HT). But it remains unknown whether raising the arms alone has the same impact. We analyzed data collected from patients enrolled by the Dystonia Coalition. For 120 patients with HT, we assessed how raising their arms without touching their head changed their HT severity. Forty-eight out of 120 patients exhibited changes in HT severity when raising their arms. These patients were more likely to exhibit decreases in HT severity (N = 35) than increases (N = 13, χ2 (1, N = 48) = 10.1, p = 0.002). Demographic factors and sensory trick efficacy were not significant predictors of whether HT severity changed when raising their arms. Raising the arms without touching the head is a posture that can reduce HT severity in some CD patients. Our results extend the concept of position-dependent motor symptoms in CD to include the position of the arms. Head tremor (HT) is a prevalent symptom of cervical dystonia (CD) that can often be disabling. This study demonstrates that raising the arms without touching the head is a posture that can reduce HT severity in some CD patients. Our findings also identify a novel form of position-dependence in CD.
- 23 June 2021
- Published by Ubiquity Press, Ltd. in Tremor and Other Hyperkinetic Movements
- Vol. 11 (1)
Open AccessDoes Raising the Arms Modify Head Tremor Severity in Cervical Dystonia?
A defining characteristic of dystonia is its position-dependence. In cervical dystonia (CD), sensory tricks ameliorate head tremor (HT). But it remains unknown whether raising the arms alone has the same impact. We analyzed data collected from patients enrolled by the Dystonia Coalition. For 120 patients with HT, we assessed how raising their arms without touching their head changed their HT severity. Forty-eight out of 120 patients exhibited changes in HT severity when raising their arms. These patients were more likely to exhibit decreases in HT severity (N = 35) than increases (N = 13, χ2 (1, N = 48) = 10.1, p = 0.002). Demographic factors and sensory trick efficacy were not significant predictors of whether HT severity changed when raising their arms. Raising the arms without touching the head is a posture that can reduce HT severity in some CD patients. Our results extend the concept of position-dependent motor symptoms in CD to include the position of the arms. Head tremor (HT) is a prevalent symptom of cervical dystonia (CD) that can often be disabling. This study demonstrates that raising the arms without touching the head is a posture that can reduce HT severity in some CD patients. Our findings also identify a novel form of position-dependence in CD.
- 21 May 2021
- Published by Wiley in Movement Disorders
- Vol. 36 (7) , 1481-1482
Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?
- 21 May 2021
- Published by Wiley in Movement Disorders
- Vol. 36 (7) , 1481-1482
Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?
- 1 November 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 419, 117205
It's tricky: Rating alleviating maneuvers in cervical dystonia
- 1 November 2020
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 419, 117205
It's tricky: Rating alleviating maneuvers in cervical dystonia
- Open Access
- 11 May 2020
- Published by Wiley in Movement Disorders
- Vol. 35 (6) , 911
Movement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 Era
- 11 May 2020
- Published by Wiley in Movement Disorders
- Vol. 35 (6) , 911
Open AccessMovement Disorder Society–Unified Parkinson's Disease Rating Scale Use in the Covid‐19 Era